The global anesthesia and respiratory devices market size was valued at USD 29.8 billion in 2018 and is expected to expand at a CAGR of 6.6% over the forecast period. Demand for anesthesia and respiratory devices is increasing due to increasing incidence of respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA).
Increasing incidence of the respiratory illness is expected to be a high-impact rendering driver in the market. According to the Australian Institute of Health and Welfare, in 2014-15, 1 in 20 Australians aged 45 or above was suffering from COPD. In addition, according to the World Health Organization (WHO), in 2016, around 251.0 million cases of COPD were reported, globally. Furthermore, according to the National Health Service (NHS), around 1.2 million people are currently suffering from COPD in U.K.
Technological advancement in anesthesia and respiratory devices over the years is expected to propel their demand. Manufacturer’s involvement in innovation in patient care through integration of enhanced patient monitors, innovative parameters, wireless devices, workflows, and integrated IT solutions further drives the demand. These advancements enabled various clinicians and anesthesiologists to deliver customized services to end users.
Furthermore, other value added services such as streamlining anesthesia documentation process, predictable patient care, and access to clinical information optimizes the process. For instance, B. Braun and Philips entered into a partnership agreement to develop advanced ultrasound guided therapy regional anesthesia.
Respiratory devices are expected to witness the fastest growth over the forecast period. Increasing prevalence of respiratory diseases, increasing number of surgeries performed, and rising healthcare expenditure are the key factors expected to fuel the segment growth.
Anesthesia devices are broadly segmented into machines and disposables. The machines include workstations, delivery machines, monitors, and ventilators. Anesthesia disposables include masks and accessories. Rising number of surgical procedures is expected to increase the usage of anesthesia, thereby propelling the demand for anesthesia devices. Key players operating in the anesthesia devices market are Drägerwerk AG & Co. KGaA Medical, GE Healthcare, Covidien, and Teleflex.
Respiratory equipment is segmented into nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, and respiratory inhalers. As of 2018, positive airway pressure devices dominated the overall anesthesia and respiratory devices market and are also anticipated to witness significant growth over the forecast period owing to rising prevalence of respiratory disorders, such as cystic fibrosis, asthma, and tuberculosis.
North America dominated the market in 2018 owing to increasing adoption of technological advanced devices in the region, increasing investments by the pharmaceutical companies, and rising healthcare expenditure.
Japan accounts for the largest market share in Asia Pacific. A significant rise in the geriatric population in Japan is boosting the growth of the market. Countries such as India and China are also anticipated to witness significant population suffering from pulmonary diseases. According to the World Health Organization (WHO), around 90% of the deaths attributed to COPD occur in low and middle income countries. In addition, according to the study published in International Journal of Pulmonary and Respiratory Sciences, in 2016, in India, COPD is the second biggest cause of death. Rise in the cases of respiratory diseases is expected to further drive the market in the emerging countries of Asia Pacific.
Prominent key players in the market are AirSep Corporation; B. Braun Medical Inc.; BD; Medtronic; Drägerwerk AG & Co. KGaA; Getinge AB; GE Healthcare; Philips Healthcare; Smiths Medical; Teleflex Inc.; and Masimo Corporation. Key players are making efforts to bring innovation in the market for sustaining in the market.
This market is highly competitive and the key players are investing in the development of unique and advanced devices. Companies are adopting many developmental strategies in emerging economies, such as Brazil and India, through acquisitions and agreements in order to increase their market shares.
Base year for estimation
Actual estimates/Historic data
2015 - 2017
2019 - 2026
Revenue in USD Million & CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Colombia, Saudi Arabia, South Africa, and UAE
Revenue, company share, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global anesthesia and respiratory devices market report on the basis of product and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Positive Airway Pressure
Bi-level positive airway pressure devices
Continuous positive airway pressure devices
Heated wire breathing circuits
Pass over humidifiers
Dry powdered inhalers
Metered dose inhaler
Fixed oxygen concentrators
Portable oxygen concentrators
Disposable Oxygen Masks
Peak Flow Meters
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."